All Stories

  1. Withdrawal effects following treatment discontinuation: A blind spot in evidence-based medicine

    Article • Med, July 2026, Elsevier

    Alexander Mathioudakis

  2. Inhaled corticosteroids and risk of cardiovascular events in chronic obstructive pulmonary disease: a nationwide cohort study in Denmark

    Article • BMJ Open, July 2026, BMJ

    Alexander Mathioudakis

  3. COPD Trial Evidence Comes from a Narrow Slice of the World: A Population Representativeness Analysis.

    Article • CHEST Journal, May 2026, Elsevier

    Professor Alexandru Corlateanu, Alexander Mathioudakis

  4. ERS International congress 2025: highlights from the airway diseases assembly

    Article • ERJ Open Research, April 2026, European Respiratory Society (ERS)

    Alexander Mathioudakis

  5. New GRADE Evidence-to-Decision Framework for Pairwise and Multiple Comparisons (GRADE Guidance 45)

    Article • Annals of Internal Medicine, March 2026, American College of Physicians

    Alexander Mathioudakis

  6. The Hidden Penalty for UK Clinical Academics: An Overlooked Inequity in Consultant Pay Progression

    Article • QJM, March 2026, Oxford University Press (OUP)

    Alexander Mathioudakis

  7. COPD and kidney disease: not so far apart?

    Article • Respiratory Medicine, March 2026, Elsevier

    Professor Alexandru Corlateanu, Serghei Covanțev, Alexander Mathioudakis

  8. GRADE Guidance: Update on Developing Good Practice Statements in Guidelines

    Article • Annals of Internal Medicine, March 2026, American College of Physicians

    Alexander Mathioudakis

  9. Plasma growth differentiation factor-15 is associated with cardiovascular events in patients hospitalized for acute exacerbation of COPD

    Article • Scientific Reports, January 2026, Springer Science + Business Media

    Alexander Mathioudakis

  10. Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Article • The Lancet Infectious Diseases, January 2026, Elsevier

    MD Pilar Rivera Ortega, Alexander Mathioudakis, Dr Fakher Rahim, Dr dan Wootton, Hugh Montgomery

  11. Disproportionate increase in COPD exacerbation risk for 3 months after discontinuing LAMA or ICS: insights from the FLAME trial

    Article • Thorax, December 2025, BMJ

    Alexander Mathioudakis, Sebastian Bate

  12. Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Article • The Lancet Infectious Diseases, September 2025, Elsevier

    Alexander Mathioudakis, MD Pilar Rivera Ortega, Dr dan Wootton, Hugh Montgomery

  13. The silent exclusion: rethinking eligibility and generalizability in clinical trials

    Article • The Lancet Regional Health - Western Pacific, August 2025, Elsevier

    Alexander Mathioudakis

  14. Chronic Obstructive Pulmonary Disease (COPD): Developments in Pharmacological Treatments

    Article • Drugs, May 2025, Springer Science + Business Media

    Alexander Mathioudakis

  15. Reduced treatment response to inhaled corticosteroids in current smokers with COPD, regardless of blood eosinophil count: insights from the FLAME trial

    Article • Thorax, May 2025, BMJ

    Sebastian Bate, Alexander Mathioudakis

  16. Beyond survival: improving lung cancer rehabilitation through standardised outcomes

    Article • ERJ Open Research, May 2025, European Respiratory Society (ERS)

    Alexander Mathioudakis

  17. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019

    Article • Nature Communications, May 2025, Springer Science + Business Media

    Dr Mohammed Kuddus, Prof. Atanu Biswas, Sumaira Mubarik, Turki Alanzi, Dr Akshaya Srikanth Bhagavathula, Birhanu Ayelign, Dr Sonu Bhaskar, Dr Nelsensius Klau Fauk, Rakesh Kumar Saroj, Professor Catarina Fonseca, Dr Sheikh M Alif, Dr Shariful Islam, Dr Vijay Kumar Chattu, Dr. Bolajoko O. Olusanya, Professor Ovidiu Constantin Baltatu, Alexander Mathioudakis, Professor Tarek Tawfik Amin, Dr Shankar M Bakkannavar, Dr Amin Mousavi Khaneghah, Dr. Alok Atreya, Professor Richard James Maude, Professor Bruno Ramos Nascimento, Godfrey Rwegerera, Professor SHAJI K S, Dr Shrikant Pawar, Dr Fakher Rahim, Dr Ruth W Kimokoti, Professor Yousef Khader, Sandra Barteit, Sok King Ong, Dr Md Nuruzzaman Khan, Dr Amr Hassan, Professor Obinna Emmanuel Onwujekwe, Dr Jessica A Kerr, Mr. Amadou Barrow, ED Doris V. Ortega-Altamirano

  18. Decoding community-acquired pneumonia: a systematic review and analysis of diagnostic criteria and definitions used in clinical trials

    Article • Clinical Microbiology and Infection, May 2025, Elsevier

    Alexander Mathioudakis

  19. Global, regional, and national burden of household air pollution, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

    Article • The Lancet, April 2025, Elsevier

    Dr Mohammed Kuddus, Sumaira Mubarik, Prof. Manpreet Singh Bhatti, Dr Sonu Bhaskar, Dr Priyadarshini Bhattacharjee, Dr Vijay Kumar Chattu, Alexander Mathioudakis, Dr Shrikant Pawar, Dr Fakher Rahim, Prince Peprah, Sandra Barteit, Professor Muayyad M Ahmad

  20. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

    Article • The Lancet Respiratory Medicine, March 2025, Elsevier

    Professor Alexandru Corlateanu, Dr Mohammed Kuddus, Assistant Professor Ashok Pandey, Dr Ibrahim Elsohaby, Dr Vijay Kumar Chattu, Alexander Mathioudakis, Prince Peprah, Dr. Najim Z. Alshahrani, Dr Priyadarshini Bhattacharjee, Mr. Amadou Barrow

  21. Predictors of treatment REsponse to inhaled corticosteroids (ICS) in Chronic Obstructive pulmonary disease: randomised controlled trials individual participant Data re-Evaluation–protocol of the ICS-RECODE individual participant data meta-analysis

    Article • BMJ Open, March 2025, BMJ

    Dr Catherine Fullwood, Sebastian Bate, Alexander Mathioudakis

  22. Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

    Article • EClinicalMedicine, March 2025, Elsevier

    Dr Shariful Islam, Alexander Mathioudakis, MD Pilar Rivera Ortega, Dr dan Wootton, Hugh Montgomery

  23. ERS Congress 2024: highlights from the Airway Diseases Assembly

    Article • ERJ Open Research, March 2025, European Respiratory Society (ERS)

    Alexander Mathioudakis

  24. Prevalence of Respiratory Viruses in Stable and Acute Asthma: A Systematic Review and Meta-Analysis

    Article • January 2025, Elsevier

    Alexander Mathioudakis

  25. Patient-centred composite scores as tools for assessment of response to biological therapy for paediatric and adult severe asthma

    Article • European Respiratory Journal, November 2024, European Respiratory Society (ERS)

    Alexander Mathioudakis, Dr Valentyna Yasinska

  26. Rethinking Blood Eosinophils for Assessing Inhaled Corticosteroids Response in COPD

    Article • CHEST Journal, November 2024, Elsevier

    Sebastian Bate, Alexander Mathioudakis

  27. Steroids in severe community-acquired pneumonia

    Article • Breathe, October 2024, European Respiratory Society (ERS)

    Alexander Mathioudakis

  28. GRADE guidance 39: using GRADE-ADOLOPMENT to adopt, adapt or create contextualized recommendations from source guidelines and evidence syntheses

    Article • Journal of Clinical Epidemiology, October 2024, Elsevier

    Alexander Mathioudakis

  29. Effect of low climate impact vs. high climate impact inhalers for patients with asthma and COPD-a nationwide cohort analysis

    Article • Respiratory Research, September 2024, Springer Science + Business Media

    Alexander Mathioudakis

  30. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050

    Article • The Lancet, September 2024, Elsevier

    Dr Mohammed Kuddus, Professor Yousef Khader, Dr Sonu Bhaskar, Dr Vijay Kumar Chattu, Prof. Mohsen Safaei, Dr Ibrahim Elsohaby, Dr Akshaya Srikanth Bhagavathula, Prince Peprah, Alexander Mathioudakis, Asrat Arja Wolde, Oluwaseun Ogundijo, Temesgen Leka Lerango, Natália Cruz-Martins, Dr Shrikant Pawar, Dr Fakher Rahim

  31. Inhaled Corticosteroids Particle Size and Risk of Hospitalization Due to Exacerbations and All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease. A Nationwide Cohort Study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, September 2024, Taylor & Francis

    Alexander Mathioudakis

  32. European Respiratory Society guidelines for the Diagnosis and Management of Pulmonary Alveolar Proteinosis

    Article • European Respiratory Journal, August 2024, European Respiratory Society (ERS)

    Dr Tiago M Alfaro, Francesco Bonella, Alexander Mathioudakis

  33. AM/PM dosing of LAMA for COPD: a randomized controlled trial protocol using digital recruitment and registries

    Article • Frontiers in Medicine, August 2024, Frontiers

    Alexander Mathioudakis

  34. Unravelling the complexity of ventilator-associated pneumonia: a systematic methodological literature review of diagnostic criteria and definitions used in clinical research

    Article • Critical Care, July 2024, Springer Science + Business Media

    Alexander Mathioudakis

  35. The state of health in the European Union (EU-27) in 2019: a systematic analysis for the Global Burden of Disease study 2019

    Article • BMC Public Health, May 2024, Springer Science + Business Media

    Dr Vijay Kumar Chattu, Alexander Mathioudakis, Natália Cruz-Martins, Sandra Barteit

  36. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

    Article • The Lancet, May 2024, Elsevier

    Shumaila Nargus, Dr Senbagam Duraisamy, Dr arnaud Iradukunda, Prof Tommi Vasankari, Dr Mohammed Kuddus, Dr Yuan-Pang Wang, Prof. Muayyad M Ahmad, Prof. Atanu Biswas, Deborah Aluh, Dr Sonu Bhaskar, Ts. Dr Adel Al-Gheethi, Dr Madhan Balasubramanian, ED Doris V. Ortega-Altamirano, Sumaira Mubarik, Dr Javad Sharifi Rad, Dr Amin Mousavi Khaneghah, Dr Ali Fatehizadeh, Mr. Ahmednur Adem Aliyi, Professor Erkin Mirrakhimov, Mr Nauman Khalid, Sok King Ong, Gebrekiros Gebremichael, Dr. Prince Michael Amegbor, Ejemai Eboreime, Prof. Manpreet Singh Bhatti, Dr. Farrokh Habibzadeh, PhD. Carla Sofia FARINHA, Turki Alanzi, Mr Auwal Abdullahi, Dr Ibrahim Elsohaby, Dr Akshaya Srikanth Bhagavathula, Dr Mohammad Hosein Amirzade-Iranaq, Dr Nelsensius Klau Fauk, Dr Jessica A Kerr, Dr Sheikh M Alif, Dr Shariful Islam, Dr Vijay Kumar Chattu, Sandra Barteit, Prince Peprah, Dr. Bolajoko O. Olusanya, Pritik A Shah, Kathryn H. Jacobsen, Mesfin Abebe, Professor Muayyad M Ahmad, Professor Ovidiu Constantin Baltatu, Alexander Mathioudakis, Professor Tarek Tawfik Amin, Dr. Alok Atreya, Professor Richard James Maude, Professor Bruno Ramos Nascimento, Dr. Georgios D Panos, Temesgen Leka Lerango, Godfrey Rwegerera, Dr. Shu Wang, Natália Cruz-Martins, Mr. Amadou Barrow, Dr Fakher Rahim, Dr Ruth W Kimokoti, Dr Amr Hassan, Dr Md Nuruzzaman Khan, Professor Obinna Emmanuel Onwujekwe

  37. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a syst...

    Article • The Lancet, May 2024, Elsevier

    Prof Tommi Vasankari, Dr Mohammed Kuddus, Dr Yuan-Pang Wang, Javier Abednego Magaña Gomez, Dr Sonu Bhaskar, Dr Senbagam Duraisamy, Ts. Dr Adel Al-Gheethi, Dr Mohammad Sami Alwardat, Dr. Tungki Pratama Umar, ED Doris V. Ortega-Altamirano, Dr Amr Hassan, Sumaira Mubarik, Dr Javad Sharifi Rad, Dr Ali Fatehizadeh, Professor Erkin Mirrakhimov, Mr Nauman Khalid, Prof Maha El Tantawi, Shumaila Nargus, Dr. Prince Michael Amegbor, Prof. Manpreet Singh Bhatti, Dr. Farrokh Habibzadeh, PhD. Carla Sofia FARINHA, Mr Auwal Abdullahi, Dr Ibrahim Elsohaby, Dr Akshaya Srikanth Bhagavathula, Dr Nelsensius Klau Fauk, Dr Jessica A Kerr, Dr Sheikh M Alif, Dr Vijay Kumar Chattu, Sandra Barteit, Prince Peprah, Dr. Bolajoko O. Olusanya, Pritik A Shah, Kathryn H. Jacobsen, Alexander Mathioudakis, Professor Tarek Tawfik Amin, Dr Shankar M Bakkannavar, Dr. Alok Atreya, Dr. Georgios D Panos, Ejemai Eboreime, Dr. Shu Wang, Natália Cruz-Martins, Mr. Amadou Barrow, Dr Shrikant Pawar, Dr Ruth W Kimokoti, Professor Obinna Emmanuel Onwujekwe

  38. Burden of disease scenarios for 204 countries

    Article • The Lancet, May 2024, Elsevier

    Oluwaseun Ogundijo, Dr Yuan-Pang Wang, Dr Salah Thabit Al Awaidy, Deborah Aluh, Dr Sonu Bhaskar, Dr Senbagam Duraisamy, Dr Ahmad Ozair, Ts. Dr Adel Al-Gheethi, Dr Mohammad Sami Alwardat, Prof. Muayyad M Ahmad, Dr Amr Hassan, Sumaira Mubarik, Dr Javad Sharifi Rad, Dr Mohammed Kuddus, Dr Ali Fatehizadeh, Professor Erkin Mirrakhimov, Mr Nauman Khalid, Dr Vahid Rashedi, Sok King Ong, Prof. Manpreet Singh Bhatti, PhD. Carla Sofia FARINHA, Turki Alanzi, Mr Auwal Abdullahi, Dr Ibrahim Elsohaby, Dr Akshaya Srikanth Bhagavathula, Dr Mohammad Hosein Amirzade-Iranaq, Dr Nelsensius Klau Fauk, Dr Omotayo Francis Fagbule, Dr Sheikh M Alif, Dr Shariful Islam, Sandra Barteit, Prince Peprah, Dr. Bolajoko O. Olusanya, Kathryn H. Jacobsen, Mesfin Abebe, Professor Muayyad M Ahmad, Professor Ovidiu Constantin Baltatu, Alexander Mathioudakis, Professor Tarek Tawfik Amin, Professor Richard James Maude, Professor Bruno Ramos Nascimento, Dr. Georgios D Panos, Dr. Shu Wang, Natália Cruz-Martins, Dr Shrikant Pawar, Ejemai Eboreime, Dr Fakher Rahim, Dr Ruth W Kimokoti, Professor Obinna Emmanuel Onwujekwe

  39. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

    Article • The Lancet, May 2024, Elsevier

    Dr Yuan-Pang Wang, Deborah Aluh, Dr Sonu Bhaskar, Dr Senbagam Duraisamy, Ts. Dr Adel Al-Gheethi, Dr Mohammad Sami Alwardat, Assistant Professor Ashok Pandey, Dr Madhan Balasubramanian, Professor Yousef Khader, Professor Alexandru Corlateanu, Dr Amr Hassan, Sumaira Mubarik, Dr Javad Sharifi Rad, Prof. Atanu Biswas, Dr Mohammed Kuddus, Dr Ali Fatehizadeh, Dr Akram Mahmoud Asbeutah, Professor Erkin Mirrakhimov, Dr Vahid Rashedi, Sok King Ong, Prof. Manpreet Singh Bhatti, Dr. Farrokh Habibzadeh, Mr Kanwar Hamza Shuja, PhD. Carla Sofia FARINHA, Turki Alanzi, Mr Auwal Abdullahi, Dr Ibrahim Elsohaby, Dr Akshaya Srikanth Bhagavathula, Dr Mohammad Hosein Amirzade-Iranaq, Dr Nelsensius Klau Fauk, Dr Omotayo Francis Fagbule, Dr. Najim Z. Alshahrani, Gizachew Taddesse AKALU, Dr Jessica A Kerr, Dr Sheikh M Alif, Sandra Barteit, Prince Peprah, Dr. Bolajoko O. Olusanya, Kathryn H. Jacobsen, Mesfin Abebe, Professor Ovidiu Constantin Baltatu, Alexander Mathioudakis, Dr Shankar M Bakkannavar, Dr. Alok Atreya, Professor Bruno Ramos Nascimento, Temesgen Leka Lerango, Dr. Shu Wang, Natália Cruz-Martins, Mr. Amadou Barrow, Dr Shrikant Pawar, Dr Fakher Rahim, Dr Ruth W Kimokoti, Dr Md Nuruzzaman Khan, Professor Obinna Emmanuel Onwujekwe

  40. Current options in the management of tree nut allergy: A systematic review and narrative synthesis

    Article • Pediatric Allergy and Immunology, May 2024, Wiley

    Alexander Mathioudakis

  41. Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO

    Article • Pediatric Allergy and Immunology, April 2024, Wiley

    Professor Adnan Custovic, Alexander Mathioudakis

  42. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021

    Article • The Lancet Infectious Diseases, April 2024, Elsevier

    Dr Priyadarshini Bhattacharjee, Ts. Dr Adel Al-Gheethi, Dr. Tungki Pratama Umar, Dr Vijay Kumar Chattu, Shumaila Nargus, Dr. Prince Michael Amegbor, Prince Peprah, Dr. Farrokh Habibzadeh, Alexander Mathioudakis, Temesgen Leka Lerango, Dr Fakher Rahim, Dr Md Nuruzzaman Khan

  43. Immunomodulatory drugs in sepsis: a systematic review and meta‐analysis

    Article • Anaesthesia, March 2024, Wiley

    Alexander Mathioudakis

  44. Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

    Article • The Lancet Child & Adolescent Health, March 2024, Elsevier

    MD Pilar Rivera Ortega, Alexander Mathioudakis, Dr dan Wootton

  45. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth

    Article • The Lancet, March 2024, Elsevier

    Shumaila Nargus, Gerald Chi, Dr Edmond Sanganyado, ED Doris V. Ortega-Altamirano, Prof. Manpreet Singh Bhatti, Dr Mohammed Kuddus, Mr Ferry Efendi, Dr Senbagam Duraisamy, Sumaira Mubarik, Dr arnaud Iradukunda, Prof Tommi Vasankari, Dr Yuan-Pang Wang, Prof. Muayyad M Ahmad, Prof. Atanu Biswas, Javier Abednego Magaña Gomez, Dr Sonu Bhaskar, Ts. Dr Adel Al-Gheethi, Assistant Professor Ashok Pandey, Dr. Tungki Pratama Umar, Dr Amr Hassan, Dr Javad Sharifi Rad, Dr Ali Fatehizadeh, Mr. Ahmednur Adem Aliyi, Dr SeyedAhmad SeyedAlinaghi, Mr Nauman Khalid, Dr Vahid Rashedi, Dr Amin Mousavi Khaneghah, Prof Maha El Tantawi, Sok King Ong, Dr Deneshkumar V, Ejemai Eboreime, Dr. Farrokh Habibzadeh, Dr. Georgios D Panos, Mr Kanwar Hamza Shuja, Turki Alanzi, Hitesh Chopra, Mr Auwal Abdullahi, Dr Ibrahim Elsohaby, Dr Akshaya Srikanth Bhagavathula, Dr Nelsensius Klau Fauk, Dr Pallav Sengupta, Gizachew Taddesse AKALU, Dr Jessica A Kerr, Dr Sheikh M Alif, Dr Shariful Islam, Dr Vijay Kumar Chattu, Dr. Bolajoko O. Olusanya, Pritik A Shah, Kathryn H. Jacobsen, Mesfin Abebe, Professor Muayyad M Ahmad, Professor Ovidiu Constantin Baltatu, Alexander Mathioudakis, Professor Tarek Tawfik Amin, Dr Shankar M Bakkannavar, Dr. Alok Atreya, Professor Richard James Maude, Professor Bruno Ramos Nascimento, Temesgen Leka Lerango, Godfrey Rwegerera, Natália Cruz-Martins, Mr. Amadou Barrow, Dr Shrikant Pawar, Dr Fakher Rahim, Dr Ruth W Kimokoti, Professor Obinna Emmanuel Onwujekwe

  46. Reply to “The use of basophil activation tests (BATs) in the diagnosis of penicillin allergy”

    Article • The Journal of Allergy and Clinical Immunology In Practice, March 2024, Elsevier

    Alexander Mathioudakis

  47. Performance Characteristics of Basophil Activation Tests for Diagnosing Penicillin Allergy: A Meta-Analysis

    Article • The Journal of Allergy and Clinical Immunology In Practice, March 2024, Elsevier

    Alexander Mathioudakis

  48. Prognostic factors for mortality, ICU, MIS-C and hospital admission due to SARS-CoV-2 in paediatric patients: A systematic review and meta-analysis

    Article • February 2024, Cold Spring Harbor Laboratory Press

    Alexander Mathioudakis

  49. Inhaledversussystemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis

    Article • European Respiratory Review, January 2024, European Respiratory Society (ERS)

    Professor Alexandru Corlateanu, Alexander Mathioudakis

  50. The Fagerström Test for Nicotine Dependence, as a prognostic factor, in current smokers with and without COPD: A cross-sectional study in northern Greece

    Article • Chronic Respiratory Disease, January 2024, SAGE Publications

    Alexander Mathioudakis

  51. Covariates in population pharmacokinetic studies of critically ill adults receiving β-lactam antimicrobials: a systematic review and narrative synthesis

    Article • JAC-Antimicrobial Resistance, December 2023, Oxford University Press (OUP)

    Alexander Mathioudakis

  52. Clinical trials of pneumonia management assess heterogeneous outcomes and measurement instruments

    Article • Journal of Clinical Epidemiology, December 2023, Elsevier

    Alexander Mathioudakis, Dr dan Wootton

  53. ERS International Congress 2023: highlights from the Airway Diseases Assembly

    Article • ERJ Open Research, November 2023, European Respiratory Society (ERS)

    Alexander Mathioudakis

  54. Prevalence and clinical implications of respiratory viruses in asthma during stable disease state and acute attacks: Protocol for a meta-analysis

    Article • PLOS One, November 2023, PLOS

    Alexander Mathioudakis

  55. Promising treatment biomarkers in asthma

    Article • Frontiers in Drug Safety and Regulation, November 2023, Frontiers

    Professor Alexandru Corlateanu, Alexander Mathioudakis

  56. Rethinking Blood Eosinophils for Assessing ICS Response in COPD: A Post-Hoc Analysis from FLAME

    Article • October 2023, Cold Spring Harbor Laboratory Press

    Sebastian Bate, Alexander Mathioudakis

  57. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019

    Article • EClinicalMedicine, October 2023, Elsevier

    Dr Mohammed Kuddus, José João Baltazar Mendes, Dr. Le Huu Nhat Minh, Dr Ali Fatehizadeh, Professor Yousef Khader, Professor Erkin Mirrakhimov, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Dr Sonu Bhaskar, Ts. Dr Adel Al-Gheethi, Dr Amr Hassan, Dr Dawit Zemedikun, Dr Vijay Kumar Chattu, Gebrekiros Gebremichael, Dr Ashish D Badiye, Kamaluddin Latief, Dr Akshaya Srikanth Bhagavathula, Dr Sheikh M Alif, Alexander Mathioudakis, Professor Colin R Simpson, Natália Cruz-Martins, Dr Shrikant Pawar, Dr Fakher Rahim

  58. Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Article • The Lancet Diabetes & Endocrinology, October 2023, Elsevier

    MD Pilar Rivera Ortega, Henry Wu, Alexander Mathioudakis, Dr dan Wootton, Hugh Montgomery

  59. Impact of self-reported environmental mould exposure on COPD outcomes

    Article • Pulmonology, September 2023, Taylor & Francis

    Alexander Mathioudakis

  60. Population pharmacokinetics critically ill beta lactam (ClinicalTrials.gov).

    Article • August 2023, CABI Publishing

    Alexander Mathioudakis

  61. Population pharmacokinetics critically ill beta lactam (Cochrane, CENTRAL).

    Article • August 2023, CABI Publishing

    Alexander Mathioudakis

  62. Population pharmacokinetics critically ill beta lactam (Embase, Ovid).

    Article • August 2023, CABI Publishing

    Alexander Mathioudakis

  63. Population pharmacokinetics critically ill beta lactam (MEDLINE (R) All, Ovid).

    Article • August 2023, CABI Publishing

    Alexander Mathioudakis

  64. Population pharmacokinetics critically ill beta lactam (Web of Science).

    Article • August 2023, CABI Publishing

    Alexander Mathioudakis

  65. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019

    Article • The Lancet, July 2023, Elsevier

    Sandra Barteit, Dr Ali Fatehizadeh, Prof Tommi Vasankari, Musa Ali, Dr Mohammad Hosein Amirzade-Iranaq, Dr Jessica A Kerr, Prince Peprah, Alexander Mathioudakis, Natália Cruz-Martins, Dr Fakher Rahim, Prof James Beeson

  66. Combined Pulmonary Fibrosis and Emphysema: Comparative Evidence on a Complex Condition

    Article • Biomedicines, June 2023, MDPI AG

    Professor Alexandru Corlateanu, Alexander Mathioudakis

  67. Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022

    Article • Breathe, June 2023, European Respiratory Society (ERS)

    Alexander Mathioudakis

  68. Current and Optimal Practices in Childhood Asthma Monitoring Among Multiple International Stakeholders

    Article • JAMA Network Open, May 2023, American Medical Association (AMA)

    Alexander Mathioudakis

  69. ERS International Congress 2022: highlights from the Airway Diseases Assembly

    Article • ERJ Open Research, April 2023, European Respiratory Society (ERS)

    Alexander Mathioudakis

  70. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

    Article • The Lancet, April 2023, Elsevier

    MD Pilar Rivera Ortega, Salman Razvi, Hugh Montgomery, Alexander Mathioudakis, Dr dan Wootton

  71. Core outcome sets, developed collaboratively with patients, can improve the relevance and comparability of clinical trials

    Article • European Respiratory Journal, April 2023, European Respiratory Society (ERS)

    Alexander Mathioudakis

  72. Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID

    Article • European Respiratory Journal, March 2023, European Respiratory Society (ERS)

    MD Pilar Rivera Ortega, Alexander Mathioudakis

  73. Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease and Risk of Acquiring Streptococcus pneumoniae Infection. A Multiregional Epidemiological Study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, March 2023, Taylor & Francis

    Dr Michael Perch, Alexander Mathioudakis

  74. Impact of triple therapy on mortality in COPD

    Article • Breathe, March 2023, European Respiratory Society (ERS)

    Alexander Mathioudakis

  75. Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis

    Article • European Respiratory Review, January 2023, European Respiratory Society (ERS)

    Alexander Mathioudakis

  76. The clinical spectrum of aspergillosis in chronic obstructive pulmonary disease

    Article • Infection, January 2023, Springer Science + Business Media

    Alexander Mathioudakis

  77. Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study

    Article • The Lancet Respiratory Medicine, January 2023, Elsevier

    Alexander Mathioudakis

  78. How to peer review: practical advice for early career researchers

    Article • Breathe, December 2022, European Respiratory Society (ERS)

    Alexander Mathioudakis

  79. Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe

    Article • European Respiratory Review, November 2022, European Respiratory Society (ERS)

    Alexander Mathioudakis

  80. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019

    Article • The Lancet Infectious Diseases, November 2022, Elsevier

    Professor Yousef Khader, Professor Andrew Toyin Olagunju, Dr. Le Huu Nhat Minh, Dr Md Nuruzzaman Khan, Additional Prof (Dr.) Paramdeep Singh, Dr Ali Fatehizadeh, Dr. Ahmed I. Hasaballah, Dr Vijay Kumar Chattu, Dr. Saif Aldeen S AlRyalat, Laszlo Lorenzovici, Dr Agha Zeeshan Mirza, Sumaira Mubarik, Musa Ali, Prof.Dr. Adnan Kisa, Dr Ashish D Badiye, Dr Aidin Abedi, Dr Akshaya Srikanth Bhagavathula, Dr Fakher Rahim, Dr. Amir Emami, Alexander Mathioudakis, Professor Colin R Simpson, Professor Richard James Maude, Natália Cruz-Martins, Mr. Amadou Barrow, Dr Shrikant Pawar, Dr Ruth W Kimokoti

  81. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis

    Article • The Lancet Public Health, November 2022, Elsevier

    Dr Sonu Bhaskar, Dr Akshaya Srikanth Bhagavathula, Alexander Mathioudakis, Natália Cruz-Martins

  82. GRADE guidance 35: update on rating imprecision for assessing contextualized certainty of evidence and making decisions

    Article • Journal of Clinical Epidemiology, October 2022, Elsevier

    Alexander Mathioudakis

  83. West Nile Disease Symptoms and Comorbidities: A Systematic Review and Analysis of Cases

    Article • Tropical Medicine and Infectious Disease, September 2022, MDPI AG

    Alexander Mathioudakis

  84. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

    Article • European Heart Journal, August 2022, Oxford University Press (OUP)

    Prof. Dr. Isabelle Opitz, Professor Yuriy M. Sirenko, Professor Anh Tuan Dinh-Xuan, Alexander Mathioudakis

  85. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

    Article • European Respiratory Journal, August 2022, European Respiratory Society (ERS)

    Stephan Rosenkranz, Rolf Berger, Professor Anh Tuan Dinh-Xuan, Alexander Mathioudakis

  86. Biomarkers of Clot Activation and Degradation and Risk of Future Major Cardiovascular Events in Acute Exacerbation of COPD: A Cohort Sub-Study in a Randomized Trial Population

    Article • Biomedicines, August 2022, MDPI AG

    Alexander Mathioudakis

  87. Peripheral neuropathy: A neglected cause of disability in COPD – A narrative review

    Article • Respiratory Medicine, August 2022, Elsevier

    Professor Alexandru Corlateanu, Serghei Covanțev, Alexander Mathioudakis

  88. Presence of antiphospholipid antibodies is associated with increased implantation failure following in vitro fertilization technique and embryo transfer: A systematic review and meta-analysis

    Article • PLOS One, July 2022, PLOS

    Alexander Mathioudakis

  89. Structural epitope profiling identifies antibodies associated with critical COVID-19 and long COVID

    Article • July 2022, Cold Spring Harbor Laboratory Press

    Alexander Mathioudakis

  90. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

    Article • The Lancet, July 2022, Elsevier

    MD Pilar Rivera Ortega, Salman Razvi, Hugh Montgomery, Alexander Mathioudakis, Dr dan Wootton

  91. Transmission of SARS-CoV-2 in educational settings in 2020: a review

    Article • BMJ Open, April 2022, BMJ

    Alexander Mathioudakis

  92. Prognostic factors for mortality, ICU and hospital admission due to SARS-CoV-2: A systematic review and meta-analysis of cohort studies in Europe

    Article • March 2022, Cold Spring Harbor Laboratory Press

    Alexander Mathioudakis

  93. Inspiring stories: the impact that being part of ERS activities can have on a professional career

    Article • Breathe, March 2022, European Respiratory Society (ERS)

    Joana Cruz, Dr. Rainer Gloeckl, Alexander Mathioudakis

  94. Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019

    Article • The Lancet Child & Adolescent Health, March 2022, Elsevier

    Joao Conde, Professor Alina Rodriguez, Sandra Barteit, Professor Stefan Lorkowski, Alexander Mathioudakis, Natália Cruz-Martins

  95. Outcomes assessed in therapeutic randomized controlled trials in hospitalized patients with COVID-19: is the meta Core Outcome Set (meta-COS) adopted?

    Article • Clinical Microbiology and Infection, March 2022, Elsevier

    Alexander Mathioudakis

  96. Adrenal suppression in patients with chronic obstructive pulmonary disease treated with glucocorticoids: Role of specific glucocorticoid receptor polymorphisms

    Article • PLOS One, February 2022, PLOS

    Alexander Mathioudakis

  97. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Article • The Lancet, February 2022, Elsevier

    MD Pilar Rivera Ortega, Salman Razvi, Hugh Montgomery, Alexander Mathioudakis, Dr dan Wootton

  98. Intermittent prophylactic antibiotics for bronchiectasis

    Article • Cochrane Database of Systematic Reviews, January 2022, Wiley

    Alexander Mathioudakis

  99. Assessing Treatment Success or Failure as an Outcome in Randomised Clinical Trials of COPD Exacerbations. A Meta-Epidemiological Study

    Article • Biomedicines, December 2021, MDPI AG

    Alexander Mathioudakis

  100. Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation

    Article • Diagnostics, December 2021, MDPI AG

    Professor Alexandru Corlateanu, Alexander Mathioudakis

  101. Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Article • The Lancet Respiratory Medicine, December 2021, Elsevier

    Alexander Mathioudakis

  102. Inhaled Phosphodiesterase Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease

    Article • Drugs, November 2021, Springer Science + Business Media

    Alexander Mathioudakis

  103. Chronic obstructive pulmonary disease and COVID-19: interrelationships

    Article • Current Opinion in Pulmonary Medicine, October 2021, Wolters Kluwer Health

    Alexander Mathioudakis

  104. The role of educational settings in the transmission chain of SARS-CoV-2 in 2020: a systematic review

    Article • October 2021, Cold Spring Harbor Laboratory Press

    Alexander Mathioudakis

  105. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations

    Article • European Respiratory Journal, October 2021, European Respiratory Society (ERS)

    Professor Alexandru Corlateanu, Dr Alexander G Mathioudakis, Jørgen Vestbo, Dr Konstantinos Panagiotis Bartziokas, Alexander Mathioudakis

  106. Automated lung sound analysis using the LungPass platform: a sensitive and specific tool for identifying lower respiratory tract involvement in COVID-19

    Article • European Respiratory Journal, September 2021, European Respiratory Society (ERS)

    Dr Alexander G Mathioudakis, Alexander Mathioudakis

  107. ERS/EAACI statement on adherence to international adult asthma guidelines

    Article • European Respiratory Review, September 2021, European Respiratory Society (ERS)

    Dr Alexander G Mathioudakis, Professor Enrico M. Clini, Alexander Mathioudakis

  108. Stigma: an unmet public health priority in COPD

    Article • The Lancet Respiratory Medicine, September 2021, Elsevier

    Alexander Mathioudakis

  109. Automated lung sound analysis using the LungPass platform: A sensitive and specific tool for identifying lower respiratory tract involvement in COVID-19

    Article • July 2021, Cold Spring Harbor Laboratory Press

    Alexander Mathioudakis

  110. Management of asthma in childhood: study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank

    Article • BMJ Open, July 2021, BMJ

    Professor Adnan Custovic, Dr Jose A. Castro-Rodriguez, Alexander Mathioudakis

  111. Corticosteroid Resistance in Smokers—A Substudy Analysis of the CORTICO-COP Randomised Controlled Trial

    Article • Journal of Clinical Medicine, June 2021, MDPI AG

    Alexander Mathioudakis

  112. ERS clinical practice guidelines on treatment of sarcoidosis

    Article • European Respiratory Journal, June 2021, European Respiratory Society (ERS)

    Alexander Mathioudakis

  113. Screening, Diagnostic and Prognostic Tests for COVID-19: A Comprehensive Review

    Article • Life, June 2021, MDPI AG

    Professor Alexandru Corlateanu, Serghei Covanțev, Alexander Mathioudakis

  114. The association between beta-blocker therapy and daytime sleepiness in obstructive sleep apnoea

    Article • Sleep and Biological Rhythms, June 2021, Springer Science + Business Media

    Professor Alexandru Corlateanu, Alexander Mathioudakis

  115. Multidimensional indices in the assessment of chronic obstructive pulmonary disease

    Article • Respiratory Medicine, June 2021, Elsevier

    Professor Alexandru Corlateanu, Serghei Covanțev, Alexander Mathioudakis

  116. Alterations in T and B cell function persist in convalescent COVID-19 patients

    Article • Med, June 2021, Elsevier

    Alexander Mathioudakis

  117. Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials

    Article • Respiratory Research, May 2021, Springer Science + Business Media

    Alexander Mathioudakis

  118. Triglyceride-Glucose Index in Non-Diabetic, Non-Obese Patients with Obstructive Sleep Apnoea

    Article • Journal of Clinical Medicine, April 2021, MDPI AG

    Alexander Mathioudakis

  119. Childhood asthma outcomes during the COVID‐19 pandemic: Findings from the PeARL multi‐national cohort

    Article • Allergy, March 2021, Wiley

    Professor Adnan Custovic, Alexander Mathioudakis

  120. Self-Reported Real-World Safety and Reactogenicity of COVID-19 Vaccines: A Vaccine Recipient Survey

    Article • Life, March 2021, MDPI AG

    Alexander Mathioudakis

  121. Self-reported real-world safety and reactogenicity of COVID-19 vaccines: An international vaccine-recipient survey

    Article • March 2021, Cold Spring Harbor Laboratory Press

    Alexander Mathioudakis

  122. P190 Systematic survey of reported outcomes in ventilator associated pneumonia randomised controlled trials

    Article • January 2021, BMJ

    Alexander Mathioudakis

  123. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis

    Article • Cochrane Database of Systematic Reviews, January 2021, Wiley

    Alexander Mathioudakis

  124. GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence—An overview in the context of health decision-making

    Article • Journal of Clinical Epidemiology, January 2021, Elsevier

    Dr John Fredrick Wambaugh, Alexander Mathioudakis

  125. Developing trustworthy recommendations as part of an urgent response (1–2 weeks): a GRADE concept paper

    Article • Journal of Clinical Epidemiology, January 2021, Elsevier

    Alexander Mathioudakis

  126. Polymorphisms of the Glucocorticoid Receptor Gene and Adrenal Suppression in Patients with Chronic Obstructive Pulmonary Disease Treated with Glucocorticoids for Acute Exacerbations

    Article • December 2020, Research Square

    Alexander Mathioudakis

  127. Outcomes Evaluated in Controlled Clinical Trials on the Management of COVID-19: A Methodological Systematic Review

    Article • Life, December 2020, MDPI AG

    Alexander Mathioudakis

  128. Current developments and future directions in COPD

    Article • European Respiratory Review, December 2020, European Respiratory Society (ERS)

    Alexander Mathioudakis

  129. COVID-19 and COPD: a narrative review of the basic science and clinical outcomes

    Article • European Respiratory Review, November 2020, European Respiratory Society (ERS)

    Alexander Mathioudakis

  130. Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Professor Adnan Custovic, Alexander Mathioudakis

  131. Outcomes evaluated in controlled clinical trials on the management of COVID-19: A methodological systematic review

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Alexander Mathioudakis

  132. Recovery of monocyte exhaustion is associated with resolution of lung injury in COVID-19 convalescence

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Alexander Mathioudakis

  133. Bone turnover biomarkers in COPD patients randomized to either a regular or shortened course of corticosteroids: a substudy of the randomized controlled CORTICO-COP trial

    Article • Respiratory Research, October 2020, Springer Science + Business Media

    Alexander Mathioudakis

  134. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19

    Article • Science Immunology, September 2020, American Association for the Advancement of Science

    Alexander Mathioudakis

  135. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden

    Article • The Journal of Allergy and Clinical Immunology In Practice, September 2020, Elsevier

    Professor Adnan Custovic, Dr Jose A. Castro-Rodriguez, Alexander Mathioudakis

  136. Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease

    Article • Clinics in Chest Medicine, September 2020, Elsevier

    Alexander Mathioudakis

  137. Severity-stratified and longitudinal analysis of VWF/ADAMTS13 imbalance, altered fibrin crosslinking and inhibition of fibrinolysis as contributors to COVID-19 coagulopathy

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Alexander Mathioudakis

  138. Comparison of the Level of Awareness about the Transmission of Echinococcosis and Toxocariasis between Pet Owners and Non-Pet Owners in Greece

    Article • International Journal of Environmental Research and Public Health, July 2020, MDPI AG

    Alexander Mathioudakis

  139. Problems arising from the conduct of multiple trials evaluating the same interventions for COVID-19

    Article • American Journal of Respiratory and Critical Care Medicine, July 2020, American Thoracic Society

    Markus Fally, Alexander Mathioudakis

  140. The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision

    Article • European Respiratory Journal, July 2020, European Respiratory Society (ERS)

    Professor Alexandru Corlateanu, Jørgen Vestbo, Dr Konstantinos Panagiotis Bartziokas, Alexander Mathioudakis

  141. Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol

    Article • ERJ Open Research, July 2020, European Respiratory Society (ERS)

    Professor Alexandru Corlateanu, Jørgen Vestbo, Dr Konstantinos Panagiotis Bartziokas, Alexander Mathioudakis

  142. Longitudinal immune profiling reveals distinct features of COVID-19 pathogenesis

    Article • June 2020, Cold Spring Harbor Laboratory Press

    Alexander Mathioudakis

  143. Research Priorities in Pediatric Asthma: Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank

    Article • The Journal of Allergy and Clinical Immunology In Practice, June 2020, Elsevier

    Professor Adnan Custovic, Dr Jose A. Castro-Rodriguez, Alexander Mathioudakis

  144. Prevalence and clinical implications of respiratory viruses in stable chronic obstructive pulmonary disease (COPD) and exacerbations: a systematic review and meta-analysis protocol

    Article • BMJ Open, April 2020, BMJ

    Alexander Mathioudakis

  145. Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits

    Article • Thorax, March 2020, BMJ

    Alexander Mathioudakis

  146. Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD

    Article • European Respiratory Journal, February 2020, European Respiratory Society (ERS)

    Jørgen Vestbo, Alexander Mathioudakis

  147. The need for clean air: The way air pollution and climate change affect allergic rhinitis and asthma

    Article • Allergy, January 2020, Wiley

    Alexander Mathioudakis

  148. ERS International Congress, Madrid, 2019: highlights from the Airway Diseases, Asthma and COPD Assembly

    Article • ERJ Open Research, January 2020, European Respiratory Society (ERS)

    Prof. Sergio Duarte Dortas Junior, Dr Sara Cuevas Ocaña, Alexander Mathioudakis

  149. Corrigendum to: Transfusion-Transmitted Malaria: A Systematic Review and Meta-Analysis

    Article • Open Forum Infectious Diseases, January 2020, Oxford University Press (OUP)

    Alexander Mathioudakis

  150. Long-Lasting Alterations in T and B Cell Function in Convalescent COVID-19 Patients

    Article • SSRN Electronic Journal, January 2020, Elsevier

    Alexander Mathioudakis

  151. A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations

    Article • ERJ Open Research, October 2019, European Respiratory Society (ERS)

    Jørgen Vestbo, Alexander Mathioudakis

  152. Laboratory Cross-Contamination of Mycobacterium tuberculosis: A Systematic Review and Meta-analysis

    Article • Lung, June 2019, Springer Science + Business Media

    Alexander Mathioudakis

  153. Transfusion-Transmitted Malaria: A Systematic Review and Meta-analysis

    Article • Open Forum Infectious Diseases, June 2019, Oxford University Press (OUP)

    Alexander Mathioudakis

  154. How do clinical trials on COPD exacerbations evaluate the effect treatments have on patients?

    Article • ERJ Open Research, April 2019, European Respiratory Society (ERS)

    Jørgen Vestbo, Dr Alexander G Mathioudakis, Alexander Mathioudakis

  155. Was the implementation strategy of the ProACT trial adequately proactive?

    Article • Breathe, March 2019, European Respiratory Society (ERS)

    Alexander Mathioudakis

  156. Chronic Airway Diseases Early Stratification (CADSET): a new ERS Clinical Research Collaboration

    Article • European Respiratory Journal, March 2019, European Respiratory Society (ERS)

    Alvar Agustí, Alexander Mathioudakis

  157. Systematic review on women's values and preferences concerning breast cancer screening and diagnostic services

    Article • Psycho-Oncology, February 2019, Wiley

    Alexander Mathioudakis

  158. Research highlights from the 2018 European Respiratory Society International Congress: airway disease

    Article • ERJ Open Research, February 2019, European Respiratory Society (ERS)

    Alexander Mathioudakis

  159. Intermittent prophylactic antibiotics for bronchiectasis

    Article • Cochrane Database of Systematic Reviews, January 2019, Wiley

    Alexander Mathioudakis

  160. What is the impact of GOLD 2017 recommendations in primary care? – a descriptive study of patient classifications, treatment burden and costs [Erratum]

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2018, Dove Medical Press

    Dr Alexander G Mathioudakis, Jørgen Vestbo, Alexander Mathioudakis

  161. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis

    Article • Cochrane Database of Systematic Reviews, November 2018, Wiley

    Alexander Mathioudakis

  162. Biomarkers to guide antibiotic therapy for COPD exacerbations

    Article • Cochrane Database of Systematic Reviews, October 2018, Wiley

    Alexander Mathioudakis

  163. Capsule Commentary on Ashburner et al., Electronic Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation: a Randomized Controlled Trial

    Article • Journal of General Internal Medicine, October 2018, Springer Science + Business Media

    Alexander Mathioudakis

  164. What is the impact of GOLD 2017 recommendations in primary care? – a descriptive study of patient classifications, treatment burden and costs

    Article • International Journal of Chronic Obstructive Pulmonary Disease, October 2018, Dove Medical Press

    Dr Alexander G Mathioudakis, Jørgen Vestbo, Alexander Mathioudakis

  165. EARLY versus MILD Chronic Obstructive Pulmonary Disease (COPD)

    Article • Respiratory Medicine, July 2018, Elsevier

    Professor Alexandru Corlateanu, Alexander Mathioudakis

  166. Continuous versus intermittent antibiotics for bronchiectasis

    Article • Cochrane Database of Systematic Reviews, June 2018, Wiley

    Alexander Mathioudakis

  167. COPD and Stroke

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, May 2018, Taylor & Francis

    Professor Alexandru Corlateanu, Serghei Covanțev, Dr Alexander G Mathioudakis, Alexander Mathioudakis

  168. The emerging Chinese COPD epidemic

    Article • The Lancet, April 2018, Elsevier

    Alexander Mathioudakis

  169. Capsule Commentary on Bremmer et. al., Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations

    Article • Journal of General Internal Medicine, February 2018, Springer Science + Business Media

    Alexander Mathioudakis

  170. Research highlights from the 2017 ERS International Congress: airway diseases in focus

    Article • ERJ Open Research, January 2018, European Respiratory Society (ERS)

    Alexander Mathioudakis, Dr Imran Satia

  171. Early Career Members at the ERS International Congress 2017: highlights from the Assemblies

    Article • Breathe, December 2017, European Respiratory Society (ERS)

    Alexander Mathioudakis, Isaac Almendros, Dimitrios Magouliotis, Sara Lundell

  172. Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis

    Article • November 2017, Springer Science + Business Media

    Alexander Mathioudakis

  173. Airways diseases: insights from the European Respiratory Society Annual Congress 2017

    Article • Journal of Thoracic Disease, November 2017, AME Publishing Company

    Alexander Mathioudakis, Dr Imran Satia

  174. ERS Early Career Members meet EAACI Junior Members: the launch of a strong, fruitful collaboration

    Article • Breathe, August 2017, European Respiratory Society (ERS)

    Dr Alexander G Mathioudakis, Alexander Mathioudakis, Dr. Sabine Bartel

  175. Continuous versus intermittent antibiotics for non-cystic fibrosis bronchiectasis

    Article • Cochrane Database of Systematic Reviews, July 2017, Wiley

    Alexander Mathioudakis

  176. GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence

    Article • Journal of Clinical Epidemiology, July 2017, Elsevier

    Alexander Mathioudakis

  177. Interventions to improve inhaler technique and adherence to inhaled corticosteroids in children with asthma

    Article • Paediatric Respiratory Reviews, June 2017, Elsevier

    Dr Alexander G Mathioudakis, Alexander Mathioudakis

  178. Opportunities for early career members

    Article • Breathe, June 2017, European Respiratory Society (ERS)

    Alexander Mathioudakis, Dr. Sabine Bartel

  179. Relationship of Allergy with Asthma: There Are More Than the Allergy “Eggs” in the Asthma “Basket”

    Article • Frontiers in Pediatrics, April 2017, Frontiers

    Dr Alexander G Mathioudakis, Alexander Mathioudakis

  180. Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer: A Systematic Review and Meta-Analysis

    Article • Clinical and Applied Thrombosis/Hemostasis, March 2017, SAGE Publications

    Professor Shaker A. Mousa, Dr Alexander G Mathioudakis, Alexander Mathioudakis

  181. Interventions to improve inhaler technique for people with asthma

    Article • Cochrane Database of Systematic Reviews, March 2017, Wiley

    Alexander Mathioudakis

  182. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis

    Article • European Respiratory Review, January 2017, European Respiratory Society (ERS)

    Professor Alexandru Corlateanu, Dr Alexander G Mathioudakis, Jørgen Vestbo, Alexander Mathioudakis

  183. Early Career Members at the ERS International Congress London 2016

    Article • Breathe, November 2016, European Respiratory Society (ERS)

    Alexander Mathioudakis, Dr. Sabine Bartel

  184. How to keep good clinical records

    Article • Breathe, November 2016, European Respiratory Society (ERS)

    Alexander Mathioudakis

  185. Prevalence and burden of comorbidities in COPD

    Article • Respiratory Investigation, November 2016, Elsevier

    Professor Alexandru Corlateanu, Serghei Covanțev, Alexander Mathioudakis

  186. Valvular-CHADS-VASc as a safer alternative to CHADS-VASc score

    Article • International Journal of Cardiology, October 2016, Elsevier

    Alexander Mathioudakis

  187. Serum procalcitonin can guide antibiotic administration for respiratory tract infections in primary care

    Article • BMJ, August 2016, BMJ

    Alexander Mathioudakis

  188. Obstructive Sleep Apnea and Hypertension: A Bidirectional Causal Relation

    Article • Current Respiratory Medicine Reviews, December 2015, Bentham Science Publishers

    Dr Alexander G Mathioudakis, Professor Alexandru Corlateanu, Alexander Mathioudakis

  189. Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnoea

    Article • Current Respiratory Medicine Reviews, December 2015, Bentham Science Publishers

    Professor Alexandru Corlateanu, Alexander Mathioudakis

  190. The risk of tachyarrhythmias in patients with moderate-to-severe chronic kidney disease receiving tiotropium bromide

    Article • International Journal of Cardiology, October 2015, Elsevier

    Dr Alexander G Mathioudakis, Alexander Mathioudakis

  191. Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 2015, Taylor & Francis

    Dr Alexander G Mathioudakis, Alexander Mathioudakis

  192. Comparative mortality risk of tiotropium administered via handihaler or respimat in COPD patients: Are they equivalent?

    Article • Pulmonary Pharmacology & Therapeutics, August 2014, Elsevier

    Dr Alexander G Mathioudakis, Alexander Mathioudakis

  193. COPD Phenotypes and Biomarkers: Introducing Personalised Medicine

    Article • Current Respiratory Medicine Reviews, July 2014, Bentham Science Publishers

    Dr Alexander G Mathioudakis, Professor Alexandru Corlateanu, Alexander Mathioudakis

  194. Management of Stable COPD: An Update

    Article • Current Respiratory Medicine Reviews, July 2014, Bentham Science Publishers

    Dr Alexander G Mathioudakis, Professor Alexandru Corlateanu, Alexander Mathioudakis

  195. Editorial from Guest Editor (Thematic Issue: Current Approach to COPD Management: Setting a Model in Medical Therapeutics)

    Article • Current Respiratory Medicine Reviews, July 2014, Bentham Science Publishers

    Dr Alexander G Mathioudakis, Alexander Mathioudakis

  196. Tiotropium HandiHaler Improves the Survival of Patients with COPD: A Systematic Review and Meta-Analysis

    Article • Journal of Aerosol Medicine and Pulmonary Drug Delivery, February 2014, Mary Ann Liebert Inc

    Dr Alexander G Mathioudakis, Alexander Mathioudakis

  197. Drugs that Act on the Respiratory Tract

    Article • January 2014, Elsevier

    Dr Alexander G Mathioudakis, Alexander Mathioudakis

  198. Expression of Bmi1, FoxF1, Nanog, and γ-Catenin in Relation to Hedgehog Signaling Pathway in Human Non-small-Cell Lung Cancer

    Article • Lung, July 2013, Springer Science + Business Media

    Dr Alexander G Mathioudakis, Alexander Mathioudakis

  199. Tiotropium Inhaler Devices: Seeking Convenience When Mortality Is at Stake?

    Article • Journal of Aerosol Medicine and Pulmonary Drug Delivery, April 2013, Mary Ann Liebert Inc

    Dr Alexander G Mathioudakis, Alexander Mathioudakis

  200. Impact of long‐term treatment with low‐dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients: Aggravating or beneficial?

    Article • Respirology, December 2012, Wiley

    Dr Alexander G Mathioudakis, Alexander Mathioudakis

  201. Chronic bronchitis: an objective diagnosis of exclusion

    Article • European Respiratory Journal, October 2012, European Respiratory Society (ERS)

    Dr Alexander G Mathioudakis, Alexander Mathioudakis